HC Wainwright & Co. Maintains Buy on Anixa Biosciences, Lowers Price Target to $6

Benzinga Newsdesk www.benzinga.com Negative 73.2%

Neg 73.2% Neu 0% Pos 0%

HC Wainwright & Co. analyst Yi Chen maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and lowers the price target from $7 to $6.